Abstract
Although incidence and mortality rates vary greatly in the world’s regions, breast cancer is the most common cancer diagnosed among women in the world, representing 21% of all newly diagnosed cases in 1990. Among women, breast cancer also is the most common cause of death from cancer (Parkin & P. Pisani, 1999). With few exceptions, the highest age-standardized incidence rates in the world are found in developed countries, and the lowest rates are in less developed countries (see Table 1). Although age-standardized incidence rates have been relatively stable in the United States in recent years (Ries et al., 2000a), rates in most other countries have been increasing, and this is especially true in developing nations. According to a recent report, the world incidence of breast cancer is projected to be 1.45 million new cases in 2010, an 82% increase over 1990 incidence estimates (Parkin & P. Pisani, 1999).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
American Cancer Society (1999). Cancer risk report: Prevention and control, 1999. Atlanta: American Cancer Society.
American Cancer Society Surveillance Program (2000). Estimated new cancer cases by sex and age. Atlanta: American Cancer Society.
American Society of Clinical Oncology (1996). Statement of the American Society of Clinical Oncology: Genetic testing for cancer susceptibility, Adopted on February 20, 1996. J Clin Oncol, 14(5), 1730–1736; discussion 1737–1740.
American Society of Human Genetics (1994). Statement of the American Society of Human Genetics on genetic testing for breast and ovarian cancer predisposition. A J Hum Genet, 55, i–iv.
Andersen, B. L., Farrar, W. B., Golden-Kreutz, D., Kutz, L. A., MacCallum, R., Courtney, M. E., & Glaser, R. (1998). Stress and immune responses after surgical treatment for regional breast cancer. J Natl Cancer Inst, 90(1), 30–36.
Bassett, L., Hendrick, R., Bassford, T. et al. (1994). Quality determinants of mammography. Clinical practice guideline No. 13 (AHCPR Publication No. 95–0632). Rockville, MD: Agency for Health Care Policy and Research, Public Health Service, U.S. Department of Health and Human Services.
Bernstein, L., Henderson, B. E., Hanisch, R., Sullivan-Halley, J., & Ross, R. K. (1994). Physical exercise and reduced risk of breast cancer in young. J Natl Cancer Inst, 86(18), 1403–1408.
Black, W. C., Nease, R. F., Jr., & Tosteson, A. N. (1995). Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. J Natl Cancer Inst, 87(10), 720–731.
Bower, J. E., Ganz, P. A., Desmond, K. A., Rowland, J. H., Meyerowitz, B. E., & Belin, T. R. (2000). Fatigue in breast cancer survivors: Occurrence, correlates, and impact on quality of life. J Clin Oncol, 18(4), 743–753.
Bowlin, S. J., Leske, M. C., Varma, A., Nasca, P., Weinstein, A., & Caplan, L. (1997). Breast cancer risk and alcohol consumption: Results from a large case-control study. Int J Epidemiol, 26(5), 915–923.
Budin, W. C. (1998). Psychosocial adjustment to breast cancer in unmarried women. Res Nurs Health, 21(2), 155–166.
Bull, A. A., Meyerowitz, B. E., Hart, S., Mosconi, P., Apolone, G., & Liberati, A. (1999). Quality of life in women with recurrent breast cancer. Breast Cancer Res Treat, 54(1), 47–51.
Carver, C. S., Pozo-Kaderman, C., Harris, S. D., Noriega, V., Scheier, M. F., Robinson, D. S., Ketcham, A. S., Moffat, F. L., Jr., & Clark, K. C. (1994). Optimism versus pessimism predicts the quality of women’s adjustment to early stage breast cancer. Cancer, 73(4), 1213–1220.
CDC (2000a). State laws relating to breast cancer. Atlanta: Centers for Disease Control Office, Program and Policy Information.
CDC (2000b). Ten years of progress: The National Breast and Cervical Cancer Early Detection Program. CDC. Available: http://www.cdc.gov/cancer/nbccedp/anniversary.htm.
Chekryn, J. (1984). Cancer recurrence: Personal meaning, communication, and marital adjustment. Cancer Nurs, 7(6), 491–498.
Cimprich, B. (1999). Pretreatment symptom distress in women newly diagnosed with breast cancer. Cancer Nurs, 22(3), 185–194; quiz 195.
Classen, C., Koopman, C., Angell, K., & Spiegel, D. (1996). Coping styles associated with psychological adjustment to advanced breast cancer. Health Psychol, 15(6), 434–437.
Colditz, G. A. (1999). Hormones and breast cancer: Evidence and implications for consideration of risks and benefits of hormone replacement therapy. J Women’s Health, 8(3), 347–357.
Colditz, G. A., Hankinson, S. E., Hunter, D. J., Willett, W. C., Manson, J. E., Stampfer, M. J., Hennekens, C., Rosner, B., & Speizer, F. E. (1995). The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med, 332(24), 1589–1593.
Colditz, G. A., Rosner, B. A., & Speizer, F. E. (1996). Risk factors for breast cancer according to family history of breast cancer. For the Nurses’ Health Study Research Group. J Natl Cancer Inst, 88(6), 365–371.
Compas, B. E., Stoll, M. F., Thomsen, A. H., Oppedisano, G., Epping-Jordan, J. E., & Krag, D. N. (1999). Adjustment to breast cancer: Age-related differences in coping and emotional distress. Breast Cancer Res Treat, 54(3), 195–203.
Day, R., Ganz, P. A., Costantino, J. P., Cronin, W. M., Wickerham, D. L., & Fisher, B. (1999). Health-related quality of life and tamoxifen in breast cancer prevention: A report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Clin Oncol, 17(9), 2659–2669.
Devesa, S. S., Silverman, D. T., Young, J. L., Jr., Pollack, E. S., Brown, C. C., Horm, J. W., Percy, C. L., Myers, M. H., McKay, F. W., & Fraumeni, J. F., Jr. (1987). Cancer incidence and mortality trends among whites in the United States, 1947–84. J Natl Cancer Inst, 79(4), 701–770.
Donegan, W. L. (1995). Diagnosis. In W. L. Donegan and J. S. Sprah (Eds.), Cancer of the breast, 4th ed. (pp. 157–205). Philadelphia: W. B. Saunders.
Dorval, M., Maunsell, E., Deschenes, L., Brisson, J., & Masse, B. (1998). Long-term quality of life after breast cancer: Comparison of 8-year survivors with population controls. J Clin Oncol, 16(2), 487–494.
Eisenberg, J. M. (1989). Clinical economics. A guide to the economic analysis of clinical practices. JAMA, 262 (20), 2879–2886.
Ellman, R., & Thomas, B. A. (1995). Is psychological well-being impaired in long-term survivors of breast cancer? J Med Screen, 2(1), 5–9.
Epping-Jordan, J. E., Compas, B. E., Osowiecki, D. M., Oppedisano, G., Gerhardt, C., Primo, K., & Krag, D. N. (1999). Psychological adjustment in breast cancer: Processes of emotional distress. Health Psychol, 18(4), 315–326.
Fine, M. K., Rimer, B. K., & Watts, P. (1993). Women’s responses to the mammography experience. J Am Board Fam Pract, 6(6), 546–555.
Fine, N. A., Musto, T. A., & Fenner, G. (2000). Breast reconstruction. In J. R. Harris, M. E. Lippman, M. Morrow, & C. K. Osborne (Eds.), Diseases of the breast, 2nd ed. (pp. 561–576). Philadelphia: Lippincott Williams & Wilkins.
Fisher, B., Costantino, J., Redmond, C., Poisson, R., Bowman, D., Couture, J., Dimitrov, N. V., Wolmark, N., Wickerham, D. L., Fisher, E. R., et al (1989). A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen receptor-positive tumors. N Engl J Med, 320(8), 479–484.
Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, M., Cronin, W. M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., Daly, M., Wieand, S., Tan-Chiu, E., Ford, L., & Wolmark, N. (1998). Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-l Study. J Natl Cancer Inst, 90(18), 1371–1388.
Food and Drug Administration (CDRH) (1999). Compliance guidance: The mammography quality standards act final regulations. Washington, D.C.: U.S. Department of Health and Human Services.
Gail, M., & Rimer, B. (1998). Risk-based recommendations for mammographic screening for women in their forties. J Clin Oncol, 16(9), 3105–3114.
Gail, M. H., Costantino, J. P., Bryant, J., Croyle, R., Freedman, L., Helzlsouer, K., & Vogel, V (1999). Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer [published erratum appears in J Natl Cancer Inst 2000 Feb 2;92(3):275]. J Natl Cancer Inst, 91(21), 1829–1846.
Ganz, P. A. (1995). Advocating for the woman with breast cancer. CA Cancer J Clin, 45(2), 114–126.
Ganz, P. A., Coscarelli, A., Fred, C., Kahn, B., Polinsky, M. L., & Petersen, L. (1996). Breast cancer survivors: Psychosocial concerns and quality of life. Breast Cancer Res Treat, 38(2), 183–199.
Gerrard, M., Gibbons, F. X., & Reis-Bergen, M. (1999). The effect of risk communication on risk perceptions: The significance of individual differences. JNCI Monographs, 25, 94–100.
Gilbert, F. J., Cordiner, C. M., Affleck, I. R., Hood, D. B., Mathieson, D., & Walker, L. G. (1998). Breast screening: The psychological sequelae of false-positive recall in women with and without a family history of breast cancer. Eur J Cancer, 34(13), 2010–2014.
Glinder, J. G., & Compas, B. E. (1999). Self-blame attributions in women with newly diagnosed breast cancer: A prospective study of psychological adjustment. Health Psychol, 18(5), 475–481.
Goldberg, J. A., Scott, R. N., Davidson, P. M., Murray, G. D., Stallard, S., George, W. D., & Maguire, G. P. (1992). Psychological morbidity in the first year after breast surgery. Eur J Surg Oncol, 18(4), 327–331.
Gram, I. T., & Slenker, S. E. (1992). Cancer anxiety and attitudes toward mammography among screening attenders, nonattenders, and women never invited. Am J Public Health, 82(2), 249–251.
Greenlee, R. T., Murray, T., Bolden, S., & Wingo, P. A. (2000). Cancer statistics, 2000. CA Cancer J Clin, 50(1), 7–33.
Henderson, B., Pike, M., Bernstein, L., & Ross, R. (1996). Breast cancer. In D. Schottenfeld & J. Fraumeni (Eds.), Cancer epidemiology and prevention. New York: Oxford University Press.
Hendrick, R. E. (1989). Quality control in mammography: The American College of Radiology’s Mammography Screening Accreditation Program. Curr Opin Radiol, 1(2), 203–211.
Hendrick, R. E. (1992). Quality assurance in mammography. Accreditation, legislation, and compliance with quality assurance standards. Radiol Clin North Am, 30(1), 243–255.
Hendrick, R. E., Smith, R. A., & Wilcox, P. A. (Eds.) (1993). ACR accreditation and legislative issues in mammography. Chicago: RSNA.
Hirshaut, Y., & Pressman, P. I. (2000). Breast cancer: The complete guide, 3rd ed. New York: Bantam Books.
Holford, T. R., Roush, G. C., & McKay, L. A. (1991). Trends in female breast cancer in Connecticut and the United States. J Clin Epidemiol, 44(1), 29–39.
Huang, Z., Hankinson, S. E., Colditz, G. A., Stampfer, M. J., Hunter, D. J., Manson, J. E., Hennekens, C. H., Rosner, B., Speizer, F. E., & Willett, W. C. (1997). Dual effects of weight and weight gain on breast cancer risk. JAMA, 278(17), 1407–1411.
Jackson, V. P., Hendrick, R. E. Kepans, D. B. (1993). Imaging the dense breast. Radiology, 188(2), 297–301.
Jenkins, P. L., May, V. E., & Hughes, L. E. (1991). Psychological morbidity associated with local recurrence of breast cancer. Int J Psychiatry Med, 21(2), 149–155.
Jordan, V. C. (1998). Antiestrogenic action of raloxifene and tamoxifen: Today and tomorrow. J Natl Cancer Inst, 90(13), 967–971.
Kelsey, J. L. (1993). Breast cancer epidemiology: Summary and future directions. Epidemiol Rev, 15(1), 256—263.
Kessler, L. G. (1992). The relationship between age and incidence of breast cancer. Population and screening program data. Cancer, 69(7 Suppl), 1896–1903.
Lee, C. O. (1997). Quality of life and breast cancer survivors. Psychosocial and treatment issues. Cancer Pract, 5(5), 309–316.
Lerman, C., Trock, B., Rimer, B. K., Boyce, A., Jepson, C., & Engstrom, P. F. (1991). Psychological and behavioral implications of abnormal mammograms. Ann Intern Med, 114(8), 651–661.
Lerman, C., Trock, B., Rimer, B. K., Jepson, C., Brody, D., & Boyce, A. (1991). Psychological side effects of breast cancer screening. Health Psychol, 10(4), 259–261.
Li, L., Qian, W., & Clarke, L. P. (1997). Digital mammography: Computer-assisted diagnosis method for mass detection with multiorientation and multiresolution wavelet transforms. Acad Radiol, 4(11), 724–731.
Liff, J. M., Sung, J. F., Chow, W. H., Greenberg, R. S., & Flanders, W. D. (1991). Does increased detection account for the rising incidence of breast cancer? Am J Public Health, 81(4), 462–465.
Lindfors, K. K., & Rosenquist, C. J. (1995). The cost-effectiveness of mammographic screening strategies [published erratum appears in JAMA 1996 Jan 10; 275(2):112]. JAMA, 274(11), 881–884.
Longman, A. J., Braden, C. J., & Mishel, M. H. (1999). Side-effects burden, psychological adjustment, and life quality in women with breast cancer: Pattern of association over time. Oncol Nurs Forum, 26(5), 909–915.
Lowe, J. B., Balanda, K. P., Del Mar, C., & Hawes, E. (1999). Psychologic distress in women with abnormal findings in mass mammography screening. Cancer, 85(5), 1114–1118.
Lynch, H. T, Lemon, S. J., Durham, C., Tinley, S. T., Connolly, C., Lynch, J. F., Surdam, J., Orinion, E., Slominski-Caster, S., Watson, P., Lerman, C., Tonin, P., Lenoir, G., Serova, O., & Narod, S. (1997). A descriptive study of BRCA1 testing and reactions to disclosure of test results. Cancer, 79(11), 2219–2228.
Maher, E. L. (1982). Anomic aspects of recovery from cancer. Soc Sci Med, 16(8), 907–912.
Maunsell, E., Brisson, J., & Deschenes, L. (1992). Psychological distress after initial treatment of breast cancer. Assessment of potential risk factors. Cancer, 70(1), 120–125.
McCaul, K. D., Branstetter, A. D., Schroeder, D. M., & Glasgow, R. E. (1996). What is the relationship between breast cancer risk and mammography screening? A meta-analytic review. Health Psychol, 15(6), 423–429.
McCaul, K. D., Sandgren, A. K., King, B., O’Donnell, S., Branstetter, A., & Foreman, G. (1999). Coping and adjustment to breast cancer. Psychooncology, 8(3), 230–236.
Meyerowitz, B. E. (1980). Psychosocial correlates of breast cancer and its treatments. Psychol Bull, 87(1), 108–131.
MMWR (1996). Trends in Cancer Screening—United States 1987 and 1992. MMWR, 45, 57–61.
Morrow, M., & Harris, J. R. (2000). Local management of invasive breast cancer. In J. R. Harris, M. E. Lippman, M. Morrow, & C. K. Osborne (Eds.), Diseases of the breast, 2nd ed. (pp. 515–560). Philadelphia: Lippincott Williams & Wilkins.
National Breast Cancer Coalition (2000). Department of Defense Breast Cancer Research Program Surpasses –1 billion. Available: http://www.natlbcc.org/bin/index.htm.
National Cancer Institute (1999a). Breast cancer risk assessment tool. Available: http://cancernet.nci.nih.gov.
National Cancer Institute (1999b). Estimated U.S. prevalence counts. Available: http://www-dccps.ims.nci.nih.gov/SRAB/Prevalence/index.html.
National Institutes of Health Consensus Development Panel (1997). National Institutes of Health Consensus Development Conference Statement: Breast Cancer Screening for Women Ages 40–49, January 21–23, 1997. National Institutes of Health Consensus Development Panel J Natl Cancer Inst, 89(14), 1015–1026.
Nayfield, S. G., Karp, J. E., Ford, L. G., Dorr, F. A., & Kramer, B. S. (1991). Potential role of tamoxifen in prevention of breast cancer. J Natl Cancer Inst, 83(20), 1450–1459.
Newman, B., Millikan, R. C., & King, M. C. (1997). Genetic epidemiology of breast and ovarian cancers. Epidemiol Rev, 19(1), 69–79.
Northouse, L. L. (1981). Mastectomy patients and the fear of cancer recurrence. Cancer Nurs, 4(3), 213–220.
Northouse, L. L. (1992). Psychological impact of the diagnosis of breast cancer on the patient and her family. J Am Med Womens Assoc, 47(5), 161–164.
Offit, K. (1998). Clinical cancer genetics. New York: Oxford University Press.
Orel, S. G., Reynolds, C., Schnall, M. D., Solin, L. J., Fraker, D. L., & Sullivan, D. C. (1997). Breast carcinoma: MR imaging before re-excisional biopsy. Radiology, 205(2), 429–436.
Page, D. L., & Jensen, R. A. (1996). Ductal carcinoma in situ of the breast: Understanding the misunderstood stepchild [editorial; comment]. JAMA, 275(12), 948–949.
Parkin, D. M., P. Pisani, J. F., & Ferlay, J. (1999). Global cancer statistics. CA Cancer J Clin, 49, 33–64.
Pasacreta, J. V. (1997). Depressive phenomena, physical symptom distress, and functional status among women with breast cancer. Nurs Res, 46(4), 214–221.
Pike, M. C. (1987). Age-related factors in cancers of the breast, ovary, and endometrium. J Chronic Dis, 40 (Suppl 2), 59S–69S.
Pike, M. C., Krailo, M. D., Henderson, B. E., Casagrande, J. T., & Hoel, D. G. (1983). ‘Hormonal’ risk factors, ‘breast tissue age’ and the age-incidence of breast cancer. Nature, 303(5920), 767–770.
Pisano, E. D., Earp, J., Schell, M., Vokaty, K., & Denham, A. (1998). Screening behavior of women after a false-positive mammogram. Radiology, 208(1), 245—249.
Polinsky, M. L. (1994). Functional status of long-term breast cancer survivors: Demonstrating chronicity [published erratum appears in Health Soc Work 1994 Nov; 19(4):297]. Health Soc Work, 19(3), 165–173.
Ries, L., Eisner, M., Kosary, C., Hankey, B., Miller, B., Clegg, L., & Edwards, B. (2000a). SEER cancer statistics review, 1973–1997. Bethesda, MD: National Cancer Institute.
Ries, L. A., Wingo, P. A., Miller, D. S., Howe, H. L., Weir, H. K., Rosenberg, H. M., Vernon, S. W., Cronin, K., & Edwards, B. K. (2000b). The annual report to the nation on the status of cancer, 1973–1997, with a special section on colorectal cancer. Cancer, 88(10), 2398–2424.
Rockhill, B., & Colditz, G. A. (1999). Making sense of breast cancer risk. Semin Breast Dis, 2(4), 272–279.
Rockhill, B., Kawachi, I., & Colditz, G. A. (2000). Individual risk prediction and population-wide disease prevention. Epidemiol Rev, 22(1), 176–180.
Rockhill, B., Weinberg, C. R., & Newman, B. (1998). Population attributable fraction estimation for established breast cancer risk factors: Considering the issues of high prevalence and unmodifiability. Am J Epidemiol, 147(9), 826–833.
Rosenquist, C. J., & Lindfors, K. K. (1998). Screening mammography beginning at age 40 years: A reappraisal of cost-effectiveness. Cancer, 82(11), 2235–2240.
Rowland, J. H., & Massie, M. J. (2000). Psychosocial issues and interventions. In J. R. Harris, M. E. Lippman, M. Morrow, & C. K. Osborne (Eds.), Diseases of the breast, 2nd ed. (pp. 1009–1031). Philadelphia: Lippincott Williams & Wilkins.
Samarel, N., Fawcett, J., & Tulman, L. (1997). Effect of support groups with coaching on adaptation to early stage breast cancer. Res Nurs Health, 20(1), 15–26.
Scaf-Klomp, W., Sanderman, R., van de Wiel, H. B., Otter, R., & van den Heuvel, W. J. (1997). Distressed or relieved? Psychological side effects of breast cancer screening in The Netherlands. J Epidemiol Community Health, 51(6), 705–710.
Schover, L. R. (1997). Sexuality and fertility after cancer. New York: Wiley.
Schwartz, L. M., Woloshin, S., Sox, H. C., Fischhoff, B., & Welch, H. G. (2000). US women’s attitudes to false positive mammography results and detection of ductal carcinoma in situ: Cross sectional survey. BMJ, 320 (7250), 1635–1640.
Shapiro, S., Coleman, E. A., Broeders, M., Codd, M., de Koning, H., Fracheboud, J., Moss, S., Paci, E., Stachenko, S., & Ballard-Barbash, R. (1998). Breast cancer screening programmes in 22 countries: Current policies, administration and guidelines. International Breast Cancer Screening Network (IBSN) and the European Network of Pilot Projects for Breast Cancer Screening. Int J Epidemiol, 27(5), 735–742.
Smigel, K. (1995). Breast cancer death rates decline for white women [news]. J Natl Cancer Inst, 87(3), 173.
Smith, R. (1995). Epidemiology of breast cancer. In D. Kopans & E. Mendelsen (Eds.), Syllabus: A categorical course in breast imaging. Chicago: Radiological Society of North America.
Smith, R. A. (1999). Risk-based screening for breast cancer: Is there a practical strategy? Semin Breast Dis, 2(4), 280–291.
Spiegel, D. (1997). Psychosocial aspects of breast cancer treatment. Semin Oncol, 24(1 Suppl 1), S1-36–S31-47.
Spiegel, D., Bloom, J. R., Kraemer, H. C., & Gottheil, E. (1989). Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet, 2(8668), 888–891.
Spiegel, D., Morrow, G. R., Classen, C., Raubertas, R., Stott, P. B., Mudaliar, N., Pierce, H. I., Flynn, P. J., Heard, L., & Riggs, G. (1999). Group psychotherapy for recently diagnosed breast cancer patients: A multi-center feasibility study. Psychooncology, 8(6), 482–493.
Stabiner, K. (1997). To dance with the devil. New York: Delacorte Press.
Stanton, A. L., & Snider, P. R. (1993). Coping with a breast cancer diagnosis: A prospective study. Health Psychol, 12(1), 16–23.
Steggles, S., Lightfoot, N., & Sellick, S. M. (1998). Psychological distress associated with organized breast cancer screening. Cancer Prev Control, 2(5), 213–220.
Struewing, J. P., Abeliovich, D., Peretz, T., Avishai, N., Kaback, M. M., Collins, F. S., & Brody, L. C. (1995). The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals [published erratum appears in Nat Genet 1996 Jan; 12(1):110]. Nat Genet, 11(2), 198–200.
Struewing, J. P., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., McAdams, M., Timmerman, M. M., Brody, L. C., & Tucker, M. A. (1997). The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med, 336(20), 1401–1408.
Sutton, S., Saidi, G., Bickler, G., & Hunter, J. (1995). Does routine screening for breast cancer raise anxiety? Results from a three wave prospective study in England. J Epidemiol Community Health, 49(4), 413–418.
Tabar, L., Dean, P. B., Duffy, S. W, & Chen, H. H. (2000). A new era in the diagnosis of breast cancer. Surg Oncol Clin N Am, 9(2), 233–277.
Tabar, L., Fagerberg, C. J., Gad, A., Baldetorp, L., Holmberg, L. H., Grontoft, O., Ljungquist, U., Lundstrom, B., Manson, J. C., Eklund, G., et al. (1985). Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet, 1(8433), 829–832.
Watson, M., Lloyd, S., Davidson, J., Meyer, L., Eeles, R., Ebbs, S., & Murday, V. (1999). The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer. Br J Cancer, 79(5–6), 868–874.
Weinstein, M. C., Siegel, J. E., Gold, M. R., Kamlet, M. S., & Russell, L. B. (1996). Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA, 276(15), 1253–1258.
White, E., Lee, C. Y., & Kristal, A. R. (1990). Evaluation of the increase in breast cancer incidence in relation to mammography use. J Natl Cancer Inst, 82(19), 1546–1552.
Zhang, S., Hunter, D. J., Forman, M. R., Rosner, B. A., Speizer, F. E., Colditz, G. A., Manson, J. E., Hankinson, S. E., & Willett, W. C. (1999). Dietary carotenoids and vitamins A, C, and E and risk of breast cancer. J Natl Cancer Inst, 91(6), 547–556.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Smith, R.A., Saslow, D. (2002). Breast Cancer. In: Wingood, G.M., DiClemente, R.J. (eds) Handbook of Women’s Sexual and Reproductive Health. Issues in Women’s Health. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0689-8_18
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0689-8_18
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5196-2
Online ISBN: 978-1-4615-0689-8
eBook Packages: Springer Book Archive